9+ Smoldering Myeloma Risk Calculator. Use only in patients recently. Prognostication tool for myeloma patients based on the genetics and other routinely used lab values in conjunction with the original iss staging system.
Provides estimation of risk of progression and prognosis in smoldering myeloma, mgus, multiple myeloma, and related plasma cell disorders. Predicts risk of progression of asymptomatic (smoldering) multiple myeloma to active myeloma or amyloidosis. Prognostication tool for myeloma patients based on the genetics and other routinely used lab values in conjunction with the original iss staging system.
Dive Into The Adventure Of Understanding Your Prognosis In Just A Few Clicks!
Use only in patients recently. Parameters are easy to enter. Provides estimation of risk of progression and prognosis in smoldering myeloma, mgus, multiple myeloma, and related plasma cell disorders.
Predicts Risk Of Progression Of Asymptomatic (Smoldering) Multiple Myeloma To Active Myeloma Or Amyloidosis.
Prior to developing multiple myeloma, patients go through precursor stages of the disease called monoclonal gammopathy of undetermined significance (mgus) or smoldering. The smoldering myeloma risk calculator assesses the risk of progression from smoldering myeloma to active myeloma. Remember, the pangea calculator tries its best but is not.
Embark On Your Medical Quest With Our Smoldering Multiple Myeloma Calculator.
Updated risk stratification model for smoldering multiple myeloma (smm) incorporating the revised imwg diagnostic criteria. Recently, mm was redefined to include biomarkers predicting a high. International myeloma working group risk stratification model for smoldering multiple.
Smoldering Multiple Myeloma (Smm) Is An Asymptomatic Precursor State Of Multiple Myeloma (Mm).
The removal of patients at the highest risk of progression from the smoldering group requires reassessment of current risk stratification models. The diagnostic criteria for mm. The pangea calculator predicts your chance of progressing from either mgus or smm to multiple myeloma in the future.
